Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers.

Polsky-Fisher SL, Vickers S, Cui D, Subramanian R, Arison BH, Agrawal NG, Goel TV, Vessey LK, Murphy MG, Lasseter KC, Simpson RC, Vega JM, Rodrigues AD.

Drug Metab Dispos. 2006 Jun;34(6):1004-11. Epub 2006 Mar 1.

PMID:
16510541
[PubMed - indexed for MEDLINE]
Free Article
2.

Subtype-selective GABA(A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023.

Atack JR.

Adv Pharmacol. 2009;57:137-85. doi: 10.1016/S1054-3589(08)57004-9. Epub 2009 Nov 27. Review.

PMID:
20230761
[PubMed - indexed for MEDLINE]
3.

GABA(A) receptor subtype-selective efficacy: TPA023, an alpha2/alpha3 selective non-sedating anxiolytic and alpha5IA, an alpha5 selective cognition enhancer.

Atack JR.

CNS Neurosci Ther. 2008 Spring;14(1):25-35. doi: 10.1111/j.1527-3458.2007.00034.x. Review.

PMID:
18482097
[PubMed - indexed for MEDLINE]
4.

The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man.

Breyer-Pfaff U.

Drug Metab Rev. 2004 Oct;36(3-4):723-46. Review.

PMID:
15554244
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk